Impact of China's Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

• 主要な著者: Miao Wang (著者), Jing Liu (著者), Brandon K. Bellows (著者), Yue Qi (著者), Jiayi Sun (著者), Jun Liu (著者), Andrew E. Moran (著者), Dong Zhao (著者)
• フォーマット: 図書
• 出版事項: Ubiquity Press, 2020-06-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Background: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China's new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. Objective: To explore the impact of...